Associate Professor Peter Simpson
Associate Professor

Peter Simpson

Email: 
Phone: 
+61 7 334 66051

Background

Peter Simpson is a recognised expert in the molecular and pathological characterisation of breast and lung cancers. His research is based at the UQ Centre for Clinical Research (UQCCR), where he is the Head of the Cancer Theme and is a Research Group Leader in Cancer Genomics. He has published >150 articles (>12,000 citations, H-index 52; Scopus, May2025) including in Nature, Nature Medicine, Annals of Oncology and the American Journal of Respiratory and Critical Care Medicine. He co-manages the Brisbane Breast Bank (BBB), a tissue bank created to facilitate clinical breast cancer research, and the Debutant lung cancer Program.

Pete also holds a teaching appointment in UQ, where he is passionate about the science and clinical applications of Pathology. He teaches into the UQ Medical Program (Year 1 and 2), as well as to undergraduates. He has co-authored a chapter ‘Breast Diseases’ in the latest edition (11th) of the internationally acclaimed Medical text book Robbins and Cotran Pathologic Basis of Disease.

Outside UQ, Pete is a Fellow of the Faculty of Science in the Royal College of Pathologists of Australasia (FFSc RCPA), a member of the kConFab Executive (https://www.kconfab.org/), a member of the Lobular Breast Cancer Alliance Scientific Advisory Board (https://lobularbreastcancer.org/), and a member of the International Cancer Genome Consortium (Breast Cancer group).

Pete enjoys supervising students at all levels in their careers and collaborating within multidisciplinary teams spanning clinical (e.g. pathology, oncology) and science teams (e.g. in ‘omics, bioinformatics and machine learning).

Availability

Associate Professor Peter Simpson is:
Available for supervision
Media expert

Fields of research

Bioinformatics and computational biology Biological Sciences Biomedical and Clinical Sciences Cancer cell biology Clinical sciences Epigenetics (incl. genome methylation and epigenomics) Genetics Genomics and transcriptomics Liquid biopsies Oncology and carcinogenesis Pathology (excl. oral pathology)

Qualifications

  • Doctor of Philosophy, University of Liverpool

Research interests

  • Broad Research Program

    Cancer is a very heterogeneous disease, making morphological classification and management of patients a significant challenge. Despite great advances it remains difficult to predict which patients are at risk of their disease returning (recurrence), spreading (metastasis) or which patients will gain most benefit to specific therapies. There has therefore been a concerted effort to supplement the morphological classification of disease with molecular data that can provide a clearer appreciation for this complexity and better predict tumour behaviour. This ideology has driven significant advancements in the field of molecular pathology research. My research program embraces these advances in technology to help better understand mechanisms of disease development and progression and help improve the molecular aspects of diagnosis and patient management. Themes of research involve 1) invasive lobular carcinoma of the breast, 2) breast cancer diagnosed in young individuals, and 3) lung cancer.

  • Invasive Lobular Carcinoma

    Invasive Lobular Carcinoma (ILC) is the most commonly diagnosed ‘special’ morphological type of breast cancer, comprising up to 15% of all cases. The most important biological feature of lobular breast cancer is the functional loss of cell adhesion molecule E-cadherin. This is the glue that holds epithelial cells together. Loss of E-cadherin leads to a growth pattern that can be diffuse and highly invasive through the breast tissue. This leads to a number of important clinical challenges with diagnosing and managing this cancer: the cancer can be hard to palpate or detect by mammographic screening and hard to fully excise during surgery; if the cancer spreads it can again be hard to detect. A large component of Peter's research focuses on aspects of this specific cancer subtype, including understanding molecular determinants that predict tumour behaviour and prognosis, and mechanisms of invasion and metastasis.

  • Familial Breast Cancer

    Family history is a significant risk factor for the development of breast cancer, often leading to early diagnosis of disease. For some families, the genetic component of this risk is well understood and attributed to pathogenic germline variants in moderate-high risk genes (e.g. BRCA1, BRCA2, PALB2, TP53, ATM, CHEK2). For many families the underlying genetic risk is unknown. Further, some individuals develop breast cancer at a young age when they have no family history. We study clinical samples using a variety of molecular profiling techniques, including whole genome sequencing and digital spatial transcriptomics, and we are interested in understanding the germline and somatic molecular mechanism that contribute to the development of disease. This work is a collaboration with several tissue banks: kConFab, the BBB and the Australian Breast Cancer Tissue Bank.

  • Lung Cancer Diagnostics

    Lung Cancer has the highest mortality of all cancers. Most cases are diagnosed at an advance, inoperable stage and so are associated with a poor prognosis. Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) sampling is an important procedure to make a tissue diagnosis of disease and to provide specimens for molecular testing. Next generation sequencing is an important component of diagnostic practice and therapeutic decision making for lung cancer patients. Our program of work is focused on optimising molecular testing strategies from different types of cancer samples (tissue, supernatant, cfDNA) to improve the success of testing for patients. This is a collaboration with A/Prof David Fielding (https://about.uq.edu.au/experts/9060) from the Department of Thoracic Medicine (RBWH), plus colleagues from Pathology Queensland, QIMR Berghofer and a network of hospitals around Australia.

Research impacts

Breast cancer is the most diagnosed cancer in women worldwide and consequently is the biggest contributor to morbidity and mortality from cancer.

My work in the field of breast cancer genomics has sought to unravel molecular mechanisms driving the evolution of disease, from early lesions through to treatment resistance and metastatic progression. Our work uses various types of ‘omics applications, including whole genome sequencing and spatial transcriptomics, married with detailed cancer morphology assessment. Gene mutations and mutational signature analysis in the context of sporadic and familial breast cancer has revealed pathogenic germline mutations, different mechanisms of genomic evolution and clonal heterogeneity. The work through the International Cancer Genome Consortium contributed to the development of HRDetect (Nature Medicine) for therapeutic decision making.

My work in lobular breast cancer has an international standing. As a research community, we aim to raise the profile of lobular breast cancer as an important, common and yet understudied type of breast cancer. We have demonstrated this disease is in fact a heterogenous subtype, exhibiting morphological variants and diverse genomic features. We developed LobSig as a potential prognostic tool for lobular breast cancer, which is undergoing further validation. We have a program of work to better understand the biology of disease and identify tissue- and blood-based biomarkers of disease progression.

Lung cancer is the highest mortality rate of all cancers worldwide. The Debutant lung cancer clinical research program was established in 2018 and has sought to optimise and expand lung cancer molecular testing applications. The work has been funded by various sources, including Pathology Queensland, Royal Brisbane & Women’s Hospital Foundation, Cancer Council Qld, Cancer Australia, Australian Genomics and the Medical Research Future Fund (MRFF). The work has demonstrated the clinical utility of very small cytology samples and blood (cfDNA) samples using comprehensive genomic assays. The translation of results from this Program could significantly enhance the number of patients eligible for targeted therapies.

Search Professor Peter Simpson’s works on UQ eSpace

218 works between 2003 and 2026
All (218) Journal Article (159) Book Chapter (15) Conference Publication (43) Other Outputs (1)

141 - 160 of 218 works

2014

Journal Article

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

Al-Ejeh, F., Simpson, P. T., Sanus, J. M., Klein, K., Kalimutho, M., Shi, W., Miranda, M., Kutasovic, J., Raghavendra, A., Madore, J., Reid, L., Krause, L., Chenevix-Trench, G., Lakhani, S. R. and Khanna, K. K. (2014). Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis, 3 (4) e100, 1-12. doi: 10.1038/oncsis.2014.14

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

2014

Journal Article

Processed pseudogenes acquired somatically during cancer development

Cooke, Susanna L., Shlien, Adam, Marshall, John, Pipinikas, Christodoulos P., Martincorena, Inigo, Tubio, Jose M. C., Li, Yilong, Menzies, Andrew, Mudie, Laura, Ramakrishna, Manasa, Yates, Lucy, Davies, Helen, Bolli, Niccolo, Bignell, Graham R., Tarpey, Patrick S., Behjati, Sam, Nik-Zainal, Serena, Papaemmanuil, Elli, Teixeira, Vitor H., Raine, Keiran, O'Meara, Sarah, Dodoran, Maryam S., Teague, Jon W., Butler, Adam P., Iacobuzio-Donahue, Christine, Santarius, Thomas, Grundy, Richard G., Malkin, David, Greaves, Mel ... Lakhani, Sunil R. (2014). Processed pseudogenes acquired somatically during cancer development. Nature Communications, 5 (1) 3644, 3644.1-3644.9. doi: 10.1038/ncomms4644

Processed pseudogenes acquired somatically during cancer development

2014

Journal Article

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women

Tilch, E., Seidens, T., Cocciardi, S., Reid, L. E., Byrne, D., Simpson, P. T., Vargas, A. C., Cummings, M. C., Fox, S. B., Lakhani, S. R. and Chenevix Trench, G. (2014). Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women. Breast Cancer Research and Treatment, 143 (2), 385-392. doi: 10.1007/s10549-013-2798-1

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women

2014

Journal Article

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Al-Ejeh, Fares, Miranda, Mariska, Shi,Wei, Simpson, Peter T., Song, Sarah, Vargas, Ana Cristina, Saunus, Jodi M., Smart, Chanel E., Mariasegaram, Mythily, Wiegmans, Adrian P., Chenevix-Trench, Georgia, Lakhani, Sunil R. and Khanna, Kum Kum (2014). Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer. Oncotarget, 5 (10), 3145-3158. doi: 10.18632/oncotarget.1865

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

2014

Conference Publication

Id4 Controls Mammary Stem Cells and Marks Breast Cancers with a Stem Cell Like Phenotype

Junankar, Simon, Baker, Laura, Roden, Daniel, Nair, Radhika, Elsworth, Ben, Lakhani, Sunil, Simpson, Peter, Ormandy C, Chris, O'Toole, Sandra and Swarbrick, Alexander (2014). Id4 Controls Mammary Stem Cells and Marks Breast Cancers with a Stem Cell Like Phenotype. Sydney Cancer Conference 2014, University of Sydney, NSW Australia, 26 November 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12282

Id4 Controls Mammary Stem Cells and Marks Breast Cancers with a Stem Cell Like Phenotype

2014

Journal Article

Rad51 supports triple negative breast cancer metastasis

Wiegmans, Adrian P., Al-Ejeh, Fares, Chee, Nicole, Yap, Pei-Yi, Gorski, Julia J., Da Silva, Leonard, Bolderson, Emma, Chenevix-Trench, Georgia, Anderson, Robin, Simpson, Peter T., Lakhani, Sunil R. and Khanna, Kum Kum (2014). Rad51 supports triple negative breast cancer metastasis. Oncotarget, 5 (10), 3261-3272. doi: 10.18632/oncotarget.1923

Rad51 supports triple negative breast cancer metastasis

2014

Journal Article

Metastatic progression of breast cancer: Insights from 50 years of autopsies

Cummings, Margaret C., Simpson, Peter T., Reid, Lynne E., Jayanthan, Janani, Skerman, Joanna, Song, Sarah, McCart Reed, Amy E., Kutasovic, Jamie R., Morey, Adrienne L., Marquart, Louise, O'Rourke, Peter and Lakhani, Sunil R. (2014). Metastatic progression of breast cancer: Insights from 50 years of autopsies. Journal of Pathology, 232 (1), 23-31. doi: 10.1002/path.4288

Metastatic progression of breast cancer: Insights from 50 years of autopsies

2013

Journal Article

miR-139-5p is a regulator of metastatic pathways in breast cancer

Krishnan, Keerthana, Steptoe, Anita, Martin, Hilary, Pattabiraman, Diwakar R., Nones, Katia, Waddell, Nicola, Mariasegaram, Mythily, Simpson, Peter T., Lakhani, Sunil R., Vlassov, Alexander, Grimmond, Sean M. and Cloonan, Nicole (2013). miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA, 19 (12), 1767-1780. doi: 10.1261/rna.042143.113

miR-139-5p is a regulator of metastatic pathways in breast cancer

2013

Journal Article

Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer

McCart Reed, Amy E., Song, Sarah, Kutasovic, Jamie R., Reid, Lynne E., Valle, Jordan M., Vargas, Ana Cristina, Smart, Chanel E. and Simpson, Peter T. (2013). Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer. Virchows Archiv, 463 (4), 535-545. doi: 10.1007/s00428-013-1468-3

Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer

2013

Journal Article

Mammographic and ultrasound features of invasive lobular carcinoma of the breast

Porter, Alan J., Evans, Elizabeth B., Foxcroft, Loani M., Simpson, Peter T. and Lakhani, Sunil R. (2013). Mammographic and ultrasound features of invasive lobular carcinoma of the breast. Journal of Medical Imaging and Radiation Oncology, 58 (1), 1-10. doi: 10.1111/1754-9485.12080

Mammographic and ultrasound features of invasive lobular carcinoma of the breast

2013

Journal Article

In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity

Smart, Chanel E., Morrison, Brian J., Saunus, Jodi M., Vargas, Ana Cristina, Keith, Patricia, Reid, Lynne, Wockner, Leesa, Amiri, Marjan Askarian, Sarkar, Debina, Simpson, Peter T., Clarke, Catherine, Schmidt, Chris W., Reynolds, Brent A., Lakhani, Sunil R. and Lopez, J. Alejandro (2013). In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PloS One, 8 (6) e64388, e64388. doi: 10.1371/journal.pone.0064388

In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity

2013

Journal Article

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

Al-Ejeh, Fares, Shi, Wei, Miranda, Mariska, Simpson, Peter T., Vargas, Ana Cristina, Song, Sarah, Wiegmans, Adrian P., Swarbrick, Alex, Welm, Alana L., Brown, Michael P., Chenevix-Trench, Georgia, Lakhani, Sunil R. and Khanna, Kum Kum (2013). Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor. Journal of Nuclear Medicine, 54 (6), 913-921. doi: 10.2967/jnumed.112.111534

Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor

2013

Journal Article

Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis

Hosein, Abdel Nasser, Song, Sarah, McCart Reed, Amy E., Jayanthan, Janani, Reid, Lynne E., Kutasovic, Jamie R., Cummings, Margaret C., Waddell, Nic, Lakhani, Sunil R., Chenevix-Trench, Georgia and Simpson, Peter T. (2013). Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis. Laboratory Investigation, 93 (6), 701-710. doi: 10.1038/labinvest.2013.54

Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis

2013

Journal Article

MicroRNA-182-5-p targets a network of genes involved in DNA repair

Krishnan, Keerthana, Steptoe, Anita L., Martin, Hilary C., Wani, Shivangi, Nones, Katia, Waddell, Nic, Mariasegaram, Mythily, Simpson, Peter T., Lakhani, Sunil R., Gabrielli, Brian, Vlassov, Alexander, Cloonan, Nicole and Grimmond, Sean M. (2013). MicroRNA-182-5-p targets a network of genes involved in DNA repair. RNA, 19 (2), 230-242. doi: 10.1261/rna.034926.112

MicroRNA-182-5-p targets a network of genes involved in DNA repair

2012

Journal Article

Expression profiling of archival tumors for long-term health studies

Waldron, Levi, Ogino, Shuji, Hoshida, Yujin, Shima, Kaori, Reed, Amy E. McCart, Simpson, Peter T., Baba, Yoshifumi, Nosho, Katsuhiko, Segata, Nicola, Vargas, Ana Cristina, Cummings, Margaret C., Lakhani, Sunil R., Kirkner, Gregory J., Giovannucci, Edward, Quackenbush, John, Golub, Todd R., Fuchs, Charles S., Parmigiani, Giovanni and Huttenhower, Curtis (2012). Expression profiling of archival tumors for long-term health studies. Clinical Cancer Research, 18 (22), 6136-6146. doi: 10.1158/1078-0432.CCR-12-1915

Expression profiling of archival tumors for long-term health studies

2012

Journal Article

Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor negative breast cancer

Peters, Amelia A., Simpson, Peter T., Bassett, Johnathon J., Lee, Jane M., Da Silva, Leonard, Reid, Lynne E., Song, Sarah, Parat, Marie-Odile, Lakhani, Sunil R., Kenny, Paraic A., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2012). Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor negative breast cancer. Molecular Cancer Therapeutics, 11 (10), 2158-2168. doi: 10.1158/1535-7163.MCT-11-0965

Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor negative breast cancer

2012

Journal Article

Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors

Smart, Chanel E., Askarian Amiri, Marjan E., Wronski, Ania, Dinger, Marcel E., Crawford, Joanna, Ovchinnikov, Dmitry A., Vargas, Ana Cristina, Reid, Lynne, Simpson, Peter T., Song, Sarah, Wiesner, Christiane, French, Juliet D., Dave, Richa K., da Silva, Leonard, Purdon, Amy, Andrew, Megan, Mattick, John S., Lakhani, Sunil R., Brown, Melissa A. and Kellie, Stuart (2012). Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. PLoS One, 7 (7) e40742, e40742.1-e40742.13. doi: 10.1371/journal.pone.0040742

Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors

2012

Journal Article

Report on emerging technologies for translational bioinformatics: A symposium on gene expression profiling for archival tissues

Waldron, Levi, Simpson, Peter, Parmigiani, Giovanni and Huttenhower, Curtis (2012). Report on emerging technologies for translational bioinformatics: A symposium on gene expression profiling for archival tissues. BMC Cancer, 12 (1) 124, 124.1-124.4. doi: 10.1186/1471-2407-12-124

Report on emerging technologies for translational bioinformatics: A symposium on gene expression profiling for archival tissues

2012

Journal Article

Molecular pathology of pre-invasive breast disease in the screening setting: Application in diagnosis and management

McCart Reed, Amy E., Cummings, Margaret C., Lakhani, Sunil R. and Simpson, Peter T. (2012). Molecular pathology of pre-invasive breast disease in the screening setting: Application in diagnosis and management. Diagnostic Histopathology, 18 (2), 64-69. doi: 10.1016/j.mpdhp.2011.11.006

Molecular pathology of pre-invasive breast disease in the screening setting: Application in diagnosis and management

2012

Journal Article

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression

Vargas, Ana Cristina, McCart Reed, Amy E., Waddell, Nic, Lane, Annette, Reid, Lynne E., Smart, Chanel E., Cocciardi, Sibylle, da Silva, Leonard, Song, Sarah, Chenevix-Trench, Georgia, Simpson Peter T. and Lakhani, Sunil R. (2012). Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Research and Treatment, 135 (1), 153-165. doi: 10.1007/s10549-012-2123-4

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression

Current funding

  • 2024 - 2028
    Reducing invasive lobular carcinoma mortality by enhanced liquid biopsy monitoring
    NHMRC MRFF Genomics Health Futures Mission
    Open grant
  • 2024 - 2026
    Prognostic biomarkers in Invasive Lobular Carcinoma
    Peter MacCallum Cancer Centre
    Open grant
  • 2023 - 2028
    kConFab. The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (National Breast Cancer Foundation grant administered by University of Melbourne)
    University of Melbourne
    Open grant
  • 2023 - 2025
    The molecular basis of breast cancer in young women
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2021 - 2025
    Improving genomic testing rates for inoperable lung cancer patients
    NHMRC MRFF Genomics Health Futures Mission
    Open grant
  • 2020 - 2025
    Whole Genome Sequencing in high-risk breast cancer patients.
    MRFF Genomics Health Futures Mission, Project Grant administered by AusIndustry
    Open grant

Past funding

  • 2023 - 2025
    High-resolution investigation of pre- and post-neoadjuvant treatment breast cancers
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2019 - 2024
    Improving the clinical management of familial breast cancers with genomics
    NHMRC Project Grant
    Open grant
  • 2018 - 2022
    Streamlining lung cancer diagnosis through genomic testing of cytology smears
    Cancer Australia
    Open grant
  • 2018 - 2020
    Streamlining lung cancer diagnosis through genomic testing of cytology smears
    Cancer Council Queensland
    Open grant
  • 2017 - 2020
    Targeting ACC1 as a novel therapeutic for the treatment of breast cancer (Cancer Australia grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2016 - 2021
    Preparing Australia for Genomic Medicine: A proposal by the Australian Genomics Health Alliance (NHMRC Targeted Call for Research administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant
  • 2016 - 2017
    Extending the strategic importance of the Australian Breast Cancer Tissue Bank to facilitate breast cancer research (NBCF Infrastructure Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2015 - 2018
    Unravelling clinical and molecular heterogeneity in metaplastic breast cancer - a unique 'stem cell like' malignancy (grant administered by Cancer Australia)
    National Breast Cancer Foundation
    Open grant
  • 2015 - 2018
    Defining the genomic and therapeutic landscape of familial breast cancer
    NHMRC Project Grant
    Open grant
  • 2015 - 2017
    Using somatic copy number and methylation profiling of circulating tumour DNA to monitor heterogeneous tumour development in breast cancer
    Cancer Council Queensland
    Open grant
  • 2014 - 2015
    The Brisbane Breast Bank
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2016
    (Dys)Regulating junctional tension: a novel mechanism in tumor cell biology
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    Prospective study of breast cancer progression by content analysis of circulating exosomes in serially collected blood samples
    Royal Brisbane and Women's Hospital
    Open grant
  • 2012 - 2015
    Margaret Taylor Scholarship for Breast Cancer Research
    Research Donation Generic
    Open grant
  • 2012 - 2015
    A systems biology approach to defining therapeutic targets in breast cancer
    NHMRC Project Grant
    Open grant
  • 2012 - 2014
    Defining therapeutic options for brain metastases
    NHMRC Project Grant
    Open grant
  • 2012 - 2014
    Re-defining the molecular evolution of breast cancer and its precursors
    Cancer Council Queensland
    Open grant
  • 2012
    Tandem fluorescent and phase-contrast imaging of live cells in real time for application to cancer cell biology, developmental biology, respiratory biology, wound healing investigation and cellular to
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Understanding the heterogeneity of invasive ductal breast cancers - a proteomic approach for the discovery of biomarkers and novel therapeutic targets (NBCF administered through QUT)
    Queensland University of Technology
    Open grant
  • 2010 - 2014
    NBCF Early Career Fellowship: Invasive lobular carcinoma of the breast: delineating mechanisms of behaviour and improving outcome
    National Breast Cancer Foundation Early Career Fellowships
    Open grant
  • 2010 - 2012
    Improving the outcome of patients with invasive lobular carcinoma of the breast
    Cancer Council Queensland
    Open grant
  • 2009 - 2012
    Calcium Influx Pathways and Breast Cancer
    NHMRC Project Grant
    Open grant
  • 2009
    Investigating the metastatic spread of lobular breast cancer
    UQ Early Career Researcher
    Open grant
  • 2007 - 2010
    Molecular Profiling of Breast Tumour Stem/Progenitor Cells
    NHMRC Project Grant
    Open grant

Availability

Associate Professor Peter Simpson is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Associate Professor Peter Simpson directly for media enquiries about their areas of expertise.

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au